| Application no. and date | 15719675.9 (espacenet) (Federated) (European Patent Register), 20150427 | | Patent/reg. no. and date | DK/EP 3250600, 20200506 | | Publication date | 20171206 | | Priority no. and date | GB 201501613, 20150130 | | EP pub. no. and date |
EP 3250600 20171206 | | Effective date | | | Applicant/owner | Biogen MA Inc., 225 Binney Street
Cambridge, MA 02142, US,
UCB Biopharma SRL, Allée de la Recherche 60
1070 Brussels, BE | | Applicant ref. no. | P72834DK01 | | Inventor | OLIVER, Ruth, IPD
UCB Celltech
208 Bath Road
Slough
Berkshire SL1 3WE, GB,
ZAMACONA, Miren, IPD
UCB Celltech
208 Bath Road
Slough
Berkshire SL1 3WE, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07K 16/28 (2006.01) | | Title | BEHANDLING AF AUTOIMMUNE LIDELSER MED CD154-ANTISTOFFER | | Int. application no. | EP2015059095 | | Int. publication no. | WO2016119909 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
